
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
Marina Elena Cazzaniga, I. Vallini, Emilia Montagna, et al.
Breast Cancer Research and Treatment (2021) Vol. 190, Iss. 3, pp. 415-424
Open Access | Times Cited: 10
Marina Elena Cazzaniga, I. Vallini, Emilia Montagna, et al.
Breast Cancer Research and Treatment (2021) Vol. 190, Iss. 3, pp. 415-424
Open Access | Times Cited: 10
Showing 10 citing articles:
Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything
Serena Capici, Luca Carlofrancesco Ammoni, Nicole Meli, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3729-3729
Open Access | Times Cited: 11
Serena Capici, Luca Carlofrancesco Ammoni, Nicole Meli, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3729-3729
Open Access | Times Cited: 11
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer
Alice Ilari, Viola Cogliati, Noorhan Sherif, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 272-272
Open Access | Times Cited: 2
Alice Ilari, Viola Cogliati, Noorhan Sherif, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 272-272
Open Access | Times Cited: 2
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2 ‐negative metastatic breast cancer
Yue Chai, Jiaxuan Liu, Mingxia Jiang, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 23, pp. 2259-2268
Open Access | Times Cited: 4
Yue Chai, Jiaxuan Liu, Mingxia Jiang, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 23, pp. 2259-2268
Open Access | Times Cited: 4
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study
Gilles Freyer, Noelia Martínez-Jáñez, Bożena Kukiełka-Budny, et al.
The Breast (2024) Vol. 74, pp. 103681-103681
Open Access | Times Cited: 1
Gilles Freyer, Noelia Martínez-Jáñez, Bożena Kukiełka-Budny, et al.
The Breast (2024) Vol. 74, pp. 103681-103681
Open Access | Times Cited: 1
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients
B. Trevisan, Francesca Fulvia Pepe, I. Vallini, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
B. Trevisan, Francesca Fulvia Pepe, I. Vallini, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study
Slavomir Krajnak, Jana Krajňáková, Katharina Anić, et al.
Breast Care (2023) Vol. 18, Iss. 2, pp. 97-105
Open Access | Times Cited: 2
Slavomir Krajnak, Jana Krajňáková, Katharina Anić, et al.
Breast Care (2023) Vol. 18, Iss. 2, pp. 97-105
Open Access | Times Cited: 2
Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: Activity and quality of life results of the GOIM 21003 trial
Laura Orlando, Evaristo Maiello, Michele Orditura, et al.
The Breast (2024) Vol. 75, pp. 103725-103725
Open Access
Laura Orlando, Evaristo Maiello, Michele Orditura, et al.
The Breast (2024) Vol. 75, pp. 103725-103725
Open Access
Current approaches to the pharmacological management of metastatic breast cancer in older women
Carlos González, Sudhir Kumar, Ines B. Menjak
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 13, pp. 1785-1794
Closed Access
Carlos González, Sudhir Kumar, Ines B. Menjak
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 13, pp. 1785-1794
Closed Access
Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape
Emily B. Jackson, Lauren Curry, Caroline Mariano, et al.
Current Oncology (2023) Vol. 31, Iss. 1, pp. 145-167
Open Access
Emily B. Jackson, Lauren Curry, Caroline Mariano, et al.
Current Oncology (2023) Vol. 31, Iss. 1, pp. 145-167
Open Access
Câncer de mama triplo negativo: avanços e perspectivas nos aspectos epidemiológicos, clínicos e terapêuticos
Letícia Cruz Gusmão, Thaiala Silva Rocha, Nicolly Barbosa Neves Luz, et al.
Revista Eletrônica Acervo Saúde (2022) Vol. 15, Iss. 11, pp. e11213-e11213
Open Access
Letícia Cruz Gusmão, Thaiala Silva Rocha, Nicolly Barbosa Neves Luz, et al.
Revista Eletrônica Acervo Saúde (2022) Vol. 15, Iss. 11, pp. e11213-e11213
Open Access